Browse studies

Find your next paid study

1 recruiting study matching your filters

EUREKA Study: Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer Using ctDNA and HARPS Biomarker Assay

This is an open-label phase 2 study to evaluate the pCR rate in patients diagnosed with HER2 positive breast cancer treated on an adaptive clinical trial desig…

HER2-positive Early-stage Breast Cancer

Rutgers, The State University of New JerseyNCT07402473